SCHEMBL14224745

SCHEMBL14224745

CCC(=O)N(Cc1ccccc1)[C@H](CO)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.50
MEN1 O00255 3/20 0.50
LMNA P02545 4/20 0.48
ALDH1A1 P00352 3/20 0.48
HSD17B10 Q99714 2/20 0.48
POLB P06746 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
KDM4E B2RXH2 1/20 0.43
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
CHRM2 P08172 1/20 0.42
CHRM4 P08173 1/20 0.42
CHRM5 P08912 1/20 0.42
MAPT P10636 1/20 0.42
CHRM1 P11229 1/20 0.42
CHRM3 P20309 1/20 0.42
BLM P54132 1/20 0.42
CYP1A2 P05177 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31117902 0.88 KMT2A (0.51) KMT2AMEN1LMNAALDH1A1HSD17B10
SCHEMBL14197223 0.82 MEN1 (0.50) KMT2AMEN1LMNAALDH1A1HSD17B10
SCHEMBL31118051 0.80 LTB4R2 (0.44) KMT2AMEN1LMNAALDH1A1HSD17B10
SCHEMBL13434089 0.79 KMT2A (0.77) KMT2AMEN1LMNAALDH1A1HSD17B10
SCHEMBL1335409 0.76 CYP2C9 (0.54) KMT2AMEN1LMNAHSD17B10KDM4E
SCHEMBL3463258 0.74 ALDH1A1 (0.60) KMT2AMEN1LMNAALDH1A1HSD17B10
SCHEMBL14017766 0.74 ADRA2B (0.50) KMT2AMEN1ALDH1A1KDM4ENPC1
SCHEMBL13452589 0.74 ADRA2B (0.50) KMT2AMEN1ALDH1A1KDM4ENPC1
SCHEMBL18079514 0.73 TSHR (0.50) KMT2AMEN1LMNAALDH1A1HSD17B10
SCHEMBL18765554 0.73 TSHR (0.50) KMT2AMEN1LMNAALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7354919-B2 Isoxazole compositions useful as inhibitors of ERK VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-04-08 US disclosed